Rubius Therapeutics (RUBY) Aiming To Make 2020 The Year Of Execution

Shares of Rubius Therapeutics Inc. (RUBY) have lost over 57 percent of their value from the yearly high of $20.04, recorded on April 5, 2019, and trade around $8.

from RTT - Biotech https://ift.tt/2P7BOwd
via IFTTT